Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Pediatrix Medical Group, Inc. (NYSE:MD) has received an average consensus rating of “Moderate Buy” from analysts, with five holding recommendations, two buys, and one strong buy.
• The stock's average 1-year price target is $16.7857, reflecting recent target revisions from various analysts, including upgrades from Leerink Partners and Zacks Research.
• Pediatrix Medical Group reported $0.53 earnings per share for the last quarter, exceeding expectations, but saw a 7.1% decline in revenue compared to the previous year.

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight analysts that are presently covering the company, MarketBeat reports. Five analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $16.7857.

A number of analysts have recently commented on the company. Leerink Partners lifted their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a research report on Friday. UBS Group boosted their target price on Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. Finally, Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of institutional investors and hedge funds have recently bought and sold shares of MD. Price T Rowe Associates Inc. MD lifted its stake in shares of Pediatrix Medical Group by 9.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 77,393 shares of the company's stock worth $1,016,000 after purchasing an additional 6,753 shares during the period. Northern Trust Corp raised its position in shares of Pediatrix Medical Group by 18.0% in the 4th quarter. Northern Trust Corp now owns 966,347 shares of the company's stock worth $12,678,000 after buying an additional 147,522 shares during the period. BNP Paribas Financial Markets raised its position in shares of Pediatrix Medical Group by 87.8% in the 4th quarter. BNP Paribas Financial Markets now owns 34,776 shares of the company's stock worth $456,000 after buying an additional 16,256 shares during the period. Deutsche Bank AG raised its position in Pediatrix Medical Group by 53.1% in the fourth quarter. Deutsche Bank AG now owns 74,023 shares of the company's stock valued at $971,000 after purchasing an additional 25,663 shares during the period. Finally, Graham Capital Management L.P. purchased a new position in Pediatrix Medical Group in the fourth quarter valued at about $463,000. Hedge funds and other institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Trading Up 0.3%

NYSE:MD opened at $17.06 on Monday. The firm has a market cap of $1.49 billion, a PE ratio of 13.22 and a beta of 1.29. The stock has a fifty day moving average price of $14.46 and a 200 day moving average price of $14.11. Pediatrix Medical Group has a 12-month low of $10.06 and a 12-month high of $17.67. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The firm had revenue of $468.84 million during the quarter, compared to analyst estimates of $464.37 million. During the same period last year, the business posted $0.34 earnings per share. Pediatrix Medical Group's revenue was down 7.1% compared to the same quarter last year. Sell-side analysts anticipate that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.